• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disseminated gonococcal infection in a patient with paroxysmal nocturnal hemoglobinuria having received ravulizumab and meningococcal vaccine.

作者信息

Yu Zhi-Ye, Tsai Ming-Jui, Lin Yu-Jen, Liu Wang-Da, Chou Sheng-Chieh, Hung Chien-Ching

机构信息

Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.

出版信息

J Microbiol Immunol Infect. 2020 Aug;53(4):660-662. doi: 10.1016/j.jmii.2020.06.013. Epub 2020 Jun 30.

DOI:10.1016/j.jmii.2020.06.013
PMID:32624359
Abstract
摘要

相似文献

1
Disseminated gonococcal infection in a patient with paroxysmal nocturnal hemoglobinuria having received ravulizumab and meningococcal vaccine.一名阵发性夜间血红蛋白尿患者在接受ravulizumab和脑膜炎球菌疫苗后发生播散性淋球菌感染。
J Microbiol Immunol Infect. 2020 Aug;53(4):660-662. doi: 10.1016/j.jmii.2020.06.013. Epub 2020 Jun 30.
2
Disseminated gonococcal infection and eculizumab--a "high risk" connection?播散性淋球菌感染与依库珠单抗——一种“高风险”关联？
Sex Transm Dis. 2014 Dec;41(12):747-8. doi: 10.1097/OLQ.0000000000000202.
3
Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab.接受依库珠单抗治疗的阵发性夜间血红蛋白尿患者发生播散性淋球菌感染。
Lancet Infect Dis. 2021 May;21(5):741. doi: 10.1016/S1473-3099(20)30930-0.
4
Gonococcal septic shock associated with eculizumab treatment.与依库珠单抗治疗相关的淋球菌性感染性休克。
Pediatr Infect Dis J. 2012 May;31(5):543. doi: 10.1097/INF.0b013e3182503849.
5
No Good Deed Goes Unpunished: Eculizumab and Invasive Neisserial Infections.善有恶报：依库珠单抗与侵袭性奈瑟菌感染
Clin Infect Dis. 2019 Aug 1;69(4):601-603. doi: 10.1093/cid/ciy959.
6
Safety of current treatments for paroxysmal nocturnal hemoglobinuria.阵发性睡眠性血红蛋白尿症当前治疗方法的安全性。
Expert Opin Drug Saf. 2021 Feb;20(2):171-179. doi: 10.1080/14740338.2021.1857723. Epub 2020 Dec 15.
7
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.一项针对既往接受依库珠单抗治疗的阵发性夜间血红蛋白尿成年患者的ravulizumab 3期随机试验的一年期结果。
Eur J Haematol. 2021 Mar;106(3):389-397. doi: 10.1111/ejh.13564. Epub 2021 Jan 3.
8
Neisseria elongata infection associated with complement inhibition during treatment of paroxysmal nocturnal haemoglobinuria.阵发性夜间血红蛋白尿治疗期间与补体抑制相关的长奈瑟菌感染。
Br J Haematol. 2018 Aug;182(3):318. doi: 10.1111/bjh.15247. Epub 2018 Apr 20.
9
Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria.瑞普昔韦单抗治疗阵发性睡眠性血红蛋白尿。
Expert Opin Biol Ther. 2020 Mar;20(3):227-237. doi: 10.1080/14712598.2020.1725468. Epub 2020 Feb 14.
10
Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿患者长期使用依库珠单抗治疗后人体抗人抗体的评估。
Am J Hematol. 2016 Mar;91(3):E16-7. doi: 10.1002/ajh.24280.

引用本文的文献

1
Therapeutic strategies targeting complement in myasthenia gravis patients.针对重症肌无力患者补体的治疗策略。
J Neurol. 2025 Jul 2;272(8):489. doi: 10.1007/s00415-025-13225-7.
2
Progression of antibiotic resistance in .……中抗生素耐药性的进展
Clin Microbiol Rev. 2025 Mar 13;38(1):e0021524. doi: 10.1128/cmr.00215-24. Epub 2025 Jan 31.
3
Genetic variability in strains isolated in a Japanese hospital.日本一家医院分离出的菌株中的基因变异性。
IJID Reg. 2024 Dec 5;14:100511. doi: 10.1016/j.ijregi.2024.100511. eCollection 2025 Mar.
4
Non-capsulated meningitidis sepsis in a paroxysmal nocturnal hemoglobinuria patient treated with ravulizumab: case report and review of the literature.利妥昔单抗治疗阵发性睡眠性血红蛋白尿症患者并发非荚膜性脑膜炎奈瑟菌败血症：病例报告及文献复习。
Front Immunol. 2023 Oct 2;14:1269325. doi: 10.3389/fimmu.2023.1269325. eCollection 2023.
5
Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.罕见炎症性肾病的治疗：靶向末端补体途径的药物。
Front Immunol. 2020 Dec 10;11:599417. doi: 10.3389/fimmu.2020.599417. eCollection 2020.